BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36451374)

  • 1. 3T sodium MR imaging in Alzheimer's disease shows stage-dependent sodium increase influenced by age and local brain volume.
    Haeger A; Boumezbeur F; Bottlaender M; Rabrait-Lerman C; Lagarde J; Mirzazade S; Krahe J; Hohenfeld C; Sarazin M; Schulz JB; Romanzetti S; Reetz K
    Neuroimage Clin; 2022; 36():103274. PubMed ID: 36451374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study.
    Ramos Bernardes da Silva Filho S; Oliveira Barbosa JH; Rondinoni C; Dos Santos AC; Garrido Salmon CE; da Costa Lima NK; Ferriolli E; Moriguti JC
    Neuroimage Clin; 2017; 15():15-24. PubMed ID: 28459000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent diffusion coefficient and sodium concentration measurements in human prostate tissue via hydrogen-1 and sodium-23 magnetic resonance imaging in a clinical setting at 3T.
    Hausmann D; Konstandin S; Wetterling F; Haneder S; Nagel AM; Dinter DJ; Schönberg SO; Zöllner FG; Schad LR
    Invest Radiol; 2012 Dec; 47(12):677-82. PubMed ID: 22996314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What can 7T sodium MRI tell us about cellular energy depletion and neurotransmission in Alzheimer's disease?
    Haeger A; Bottlaender M; Lagarde J; Porciuncula Baptista R; Rabrait-Lerman C; Luecken V; Schulz JB; Vignaud A; Sarazin M; Reetz K; Romanzetti S; Boumezbeur F
    Alzheimers Dement; 2021 Nov; 17(11):1843-1854. PubMed ID: 34855281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of the prostate: Comparing total sodium concentration quantification in prostate cancer and normal tissue using dedicated
    Barrett T; Riemer F; McLean MA; Kaggie JD; Robb F; Warren AY; Graves MJ; Gallagher FA
    J Magn Reson Imaging; 2020 Jan; 51(1):90-97. PubMed ID: 31081564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Sodium (
    Mohamed SA; Herrmann K; Adlung A; Paschke N; Hausner L; FrÖlich L; Schad L; Groden C; Kerl HU
    In Vivo; 2021; 35(1):429-435. PubMed ID: 33402493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between "Brain-Age Score" (BAS) and traditional neuropsychological screening tools in Alzheimer's disease.
    Beheshti I; Maikusa N; Matsuda H
    Brain Behav; 2018 Aug; 8(8):e01020. PubMed ID: 29931756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Brain Sodium MRI Depicts Corticospinal Impairment in Amyotrophic Lateral Sclerosis.
    Grapperon AM; Ridley B; Verschueren A; Maarouf A; Confort-Gouny S; Fortanier E; Schad L; Guye M; Ranjeva JP; Attarian S; Zaaraoui W
    Radiology; 2019 Aug; 292(2):422-428. PubMed ID: 31184559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.
    Hua X; Leow AD; Parikshak N; Lee S; Chiang MC; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neuroimage; 2008 Nov; 43(3):458-69. PubMed ID: 18691658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Changes of Cortical Thickness in Alzheimer Disease With MRI Using Freesurfer Software.
    Sattari N; Faeghi F; Shekarchi B; Heidari MH
    Basic Clin Neurosci; 2022; 13(2):185-192. PubMed ID: 36425945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.
    Prestia A; Baglieri A; Pievani M; Bonetti M; Rasser PE; Thompson PM; Marino S; Bramanti P; Frisoni GB
    Suppl Clin Neurophysiol; 2013; 62():67-80. PubMed ID: 24053032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer's Disease Based on Three Chinese MRI Datasets.
    Wei Y; Huang N; Liu Y; Zhang X; Wang S; Tang X
    Curr Alzheimer Res; 2020; 17(13):1221-1231. PubMed ID: 33602087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
    Colato E; Chiotis K; Ferreira D; Mazrina MS; Lemoine L; Mohanty R; Westman E; Nordberg A; Rodriguez-Vieitez E;
    J Alzheimers Dis; 2021; 84(1):103-117. PubMed ID: 34511502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain sodium MRI in human epilepsy: Disturbances of ionic homeostasis reflect the organization of pathological regions.
    Ridley B; Marchi A; Wirsich J; Soulier E; Confort-Gouny S; Schad L; Bartolomei F; Ranjeva JP; Guye M; Zaaraoui W
    Neuroimage; 2017 Aug; 157():173-183. PubMed ID: 28602596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
    Elder GJ; Mactier K; Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
    Int J Geriatr Psychiatry; 2017 Nov; 32(11):1182-1189. PubMed ID: 28425185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.
    Liu W; Au LWC; Abrigo J; Luo Y; Wong A; Lam BYK; Fan X; Kwan PWL; Ma HW; Ng AYT; Chen S; Leung EYL; Ho CL; Wong SHM; Chu WC; Ko H; Lau AYL; Shi L; Mok VCT;
    Aging (Albany NY); 2021 May; 13(10):13496-13514. PubMed ID: 34091443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.